Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
2.360
-0.090 (-3.67%)
At close: Oct 28, 2025, 4:00 PM EDT
2.440
+0.080 (3.39%)
Pre-market: Oct 29, 2025, 6:42 AM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $8.97 million as of October 29, 2025. Its market cap has increased by 25.29% in one year.
Market Cap
8.97M
Enterprise Value
3.35M
1-Year Change
25.29%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $8.97M, a decrease of -99.22%. That is a compound annual growth rate of -67.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 9.31M | 47.79% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | 1.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 449.42B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |